.png)
SAN DIEGO & PARIS - Scientist.com, the life science industry’s leading online marketplace for outsourced research, and the Brain and Spine Institute incubator, iPEPS-ICM, the first innovation accelerator dedicated to brain diseases in France, announced that Cerebrum Therapeutics won a biotech pitch competition with a prize package that includes 6 months free rent at iPEPS’ state-of-the-art facilities located in Paris’ 13th district and $10K USD in research services provided through the Scientist.com marketplace. Runner-up Cairn Biosciences will receive 3 months free rent at iPEPS and $6K USD in research services through Scientist.com.
“It is an honor to be recognized by the Brain and Spine Institute and Scientist.com for our efforts to develop novel treatments for brain diseases and injuries,” said Vincent Serra, CEO and Co-Founder of Cerebrum Therapeutics. “The prizes will go a long way toward accelerating our breakthrough approach to testing promising chemical and biological properties in the CNS field.”
Based in Paris, France, Cerebrum Therapeutics develops first-in-class small chemical molecules for the treatment of neurodegenerative diseases and brain injuries. Their first program is dedicated to development of a new drug to target the Tauopathy indication, with orphan drug designation. San Francisco, USA-based Cairn Biosciences, who finished second in the competition, develops next-generation therapeutics that overcome resistance to cancer therapy. Cairn’s drug discovery engine addresses the profound unmet need for new tools to decipher cellular complexity and enable scalable discovery of groundbreaking therapies.
“This startup call is aimed at helping young biotech entrepreneurs fast track the development of their innovative projects in one of the most thriving research and innovation ecosystems in Europe,” commented Dan Kagan, PhD, COO of Scientist.com. “It’s these types of collaborative efforts that will help find cures for neurological disorders, which affect nearly a billion people globally.”
About the Brain and Spine Institute
Located in the heart of the Pitié-Salpêtrière University Hospital Center, the first neurology hospital in France, the Brain and Spine Institute (ICM) is a strong link between basic research and the clinical world. The Institute consists of over 700 researchers and clinicians, 12 cutting-edge technological platforms and 1000m² office space intended for incubation of startups. The objective is to produce ambitious research by combining scientific creativity and therapeutic purpose.
.webp)
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.